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Original Investigation
Objective: The aim of this study is to determine the 
sensitivity and specificity of positron emission tomog-
raphy-computed tomography (PET-CT) in the evalu-
ation of cervical lymph node metastasis in oral cavity 
squamous cell cancers (SCCs) and to determine the 
SUV-max values in differentiating reactive and meta-
static lymph nodes as a supportive parameter.
Methods: In this study, 23 patients were included who 
were diagnosed with oral cavity SCC and treated with 
surgery between 2006 and 2013 in our department. All 
the patients were scanned with PET-CT during the 
pretreatment evaluation. Detailed pretreatment PET-
CT (retention sites and SUV-max values) and histo-
pathological examination results were obtained. SPSS 
17.0 software package was used for statistical analysis of 
the data. Categorical measurement was summarized as 
number and percentage and continuous measurements 
as mean and standard deviation (median and mini-
mum–maximum where necessary). Chi-square test or 
Fisher’s test were used in the comparison of categori-
cal variables. Compliance of methods was assessed by 
Kappa coefficient analysis. In this study, the advantag-
es of PET-CT were determined by the calculation of 
sensitivity and specificity values with histopathological 
examination results considered as the gold standard, and 
SUV-max value was assessed by examining the area un-
der the ROC curve. In all tests, the level of statistical 
significance was accepted as 0.05.
Results: The threshold value for SUV-max depending 
on the data of the histopathological examination and 
results of PET-CT of the 23 patients was 2.50. The reli-
ability of this threshold was determined as AUC=0.819. 
In demonstrating neck metastasis in patients with can-
cer of the oral cavity, PET-CT has a sensitivity of 89% 
and specificity of 98%. Compliance between the histo-
pathological examination and PET-CT for metastatic 
cervical lymph nodes was determined to be 0.416 by 
kappa coefficient analysis.
Conclusion: There was FDG uptake on PET-CT in the 
cervical lymph node regions of all patients with meta-
static cervical lymph nodes. There were no metastases in 
any of the patients with no FDG retention. The sensitiv-
ity and specificity of PET-CT in determining cervical 
lymph node metastasis were 89% and 98%, respectively, 
with a threshold SUV-max value considered as 2.50 in 
patients with FDG retention.
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Introduction
Oral cavity cancer is the sixth most common can-
cer type worldwide. Presence of cervical lymph 
node metastasis, location of the tumor and its 
size are the most important prognostic factors in 
the patients with head and neck squamous cell 
carcinoma (SCC)(1, 2). Routine staging method 
for preoperative detection of cervical lymph node 
metastasis in the patients with oral cavity SCC 
comprised of physical examination and comput-
ed tomography (CT)/ magnetic resonance imag-
ing (MRI) (3, 4). Positron emission tomography 
(PET) imaging also took its place in this evalu-
ation by the recent technological developments. 
Histopathologic examination with neck dissection 
is the most reliable staging method giving signifi-
cant prognostic information.
Fluorine-18 fluorodeoxyglucose (18F-FDG) PET 
is a functional imaging technique providing data 
about tissue metabolism and having been applied 
successfully in the evaluation of head and neck 
cancer. Standardized uptake value (SUV) is a 
numerical criterion used in the separation of the 
lesions as malign/benign, by indicating whether 
a lesion has increased 18F-FDG activity (5). The 
aim of the study is to determine PET-CT’s sen-
sitivity and specifity for evaluating cervical lymph 
node metastasis in oral cavity SCC’s and to detect 
maximum standardized uptake value (SUV-max) 
as a supportive parameter in reactive and metastat-
ic lymph node separation.
Methods
Twenty three patients who were diagnosed with 
oral cavity SCC, administered surgical treatment 
and scanned with PET-CT in our clinic between 2006-2013 
were included in the study. The PET-CT results (involvement 
locations and SUV-max values) and histopathologic examina-
tion results were obtained. The approval for this retrospective 
study was received from Başkent University Medicine Faculty 
Clinical Studies Committee (KA13/156). Whole body images 
of the patients were taken after the 60 minutes resting phase 
following intravenous injection of 370-555 MBq (10-15 mCi) 
18F-FDG by using PET-CT (Discovery-STE 8; General 
Electric Medical System, Milwaukee, WI). The patients were 
required to be fasting for 6 hours prior to the examination it 
was paid attention that blood glucose levels were under 200mg/
dl. The patients spent the resting period without moving and 
speaking in a quiet room. Firstly their non-contrast-enhanced 
(section thickness of 3,3 mm) images at the dose of attenuation 
(140 kV, 80 mA)in vertex-thigh level and just after that their 3D 
mode 3 min/bed position PET images were taken. Combined 
(fusion) images for attenuation corrections were obtained by us-
ing CT images. In our study, neck dissection and cervical lymph 
node regions were defined taking into consideration American 
Academy of Otolaryngology Head and Neck guidelines (AAO-
HNS) (6). 
Statistical Analysis
SPSS 17.0 (SPSS Inc. 233 South Wacker Drive, 11th 
Floor Chicago, IL 60606-6412) packaged software was 
used in statistical analysis of the data. Categorical mea-
surements were summarized as numerical and percentage 
and continuous measurements were summarized as mean 
and standard deviation (median and minimum-maximum 
where necessary). Chi Square Test or Fisher’s Test were 
used in comparison of categorical variables. The concor-
dance among the methods was evaluated with Kappa Con-
cordance Analysis.
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Table 1. Tumor localizations of the cases and phases
Features Number of cases %
Localization  
 Tongue 12 52.1
 Lip 4 17.4
Buccal 3 13
 Mouth floor 2 8.7
Alveolar process 2 8.7
T  
 T1 8 34.8
 T2 9 39.1
 T3 2 8.7
 T4 4 17.4
N  
 N0 16 69.6
 N1 2 8.7
 N2b 2 8.7
 N2c 3 13
Phase  
 1 8 34.8
 2 4 17.4
 3 4 17.4
 4 7 30.4
Figure 2. PET-CT axial image of the patient having SUV-max value 
of 15.4 at the right first region
Figure 1. ROC Curve 
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Histopathologic examination results were accepted as golden 
standard; superiorities, sensitivity and specifity values were cal-
culated and the area below ROC curve for SUV-max value is 
examined and evaluated. Statistical significance level in all tests 
was taken as 0.05.
Results
Eight female (34.8%), 15 male (65.2%) patients and totally 23 
patients were included in the study. The mean age of the patients 
was 57.4 (35-77) years. The diagnoses for which patients were 
treated were tongue SCC in 12 patients (52.1%), lip SCC in 4 
patients (17.4%), buccal SCC in 3 patients (13%), floor of the 
mouth SCC in 2 patients (8.7%), and alveolar process SCC in 2 
patients (8.7%) (Table 1). 
PET-CT was applied to all patients 9.04 days on average be-
fore the operation (2-24). Primary tumor surgery with neck 
dissection was administered to all of the patients. Twenty eight 
metastatic lymph nodes at 15 levels in 7 patients were detected. 
Preoperative PET-CT and histopathological examination re-
sults were compared with respect to metastatic involvement in 
the neck (Table 2).
Turk Arch Otorhinolaryngol 2015; 53: 67-72 Çaylaklı et al. Oral Cavity SCC and PET-CT 69
Table 2. Comparison of 23 patient’s histopathological examination and PET-CT results with regard to metastatic lymph node
    Neck Dissection                                     PET-CT 
  Right   Left                                Right                                     Left   
 Dissected  MLN  Number  Dissected MLN Number  FDG  FDG  PET-BT- Clinical  
Patient levels localization of MLN  levels localization of MLN localization SUV-max  localization SUV-max Operation stage 
1. M.Ö level  2-5 - - - - - - - - - 3 DAY T2N0M0
2.T.I level 1-4 - - level 1-4 - - level 2 3.9 level 2 3.9 9 DAY T1N0M0
3.A.U level 1-3 - - level 1-3 - - level 2 4.5 level 1 and  2 4.7 and 3.6 15 DAY T1N0M0
4.D.G - - - level 1-3 - - - - - - 9 DAY T1N0M0
5.M.K level 1-3 - - level 1-5 - - level 2 3.1 level 1 4.6 24 DAY T2N0M0
6.R.Y - - - level 1-5  - - - - - - 6 DAY T2N0M0
7.Y.E level  1-5 level 1 6  - - - level 1 15.4 level 2 2.7 2 DAY T1N1M0
8.M.A.Ş level  1-3 - - level 1-3 - - - - level 1 and 2 4 and 2.9 2 DAY T1N1M0
9.M.G - - - level 1-5  level 1,2 and 3 1,4, and 3  - - level 1 and 2  10.3 11 DAY T4N2cM0
10.M.A - - - level 1-3 - - - - - - 8  DAY T2N0M0
11.A.Ş level  1-4 - - - - - - - - - 20 DAY T1N0M0
12.F.A level 1-5 level 1 and 2 2 and 2  level 1-3 level 1 1  level 1 and 2  5.6 level 1  5.6 2 DAY T4N1M0
13.M.Z level 2-4 level 2 1  level 2-4 - - level 2 1.8 - - 7 DAY T2N0M0
14.M.Y level 1-4 - - - - - level 2 3.5 - - 6 DAY T1N0M0
15.N.S level 1-4 - - level 2-4 - - - - level 1 2.7 18 DAY T1N0M0
16.O.D level 1-5 - - level 1-5  level 1 and 3 2 and 1  - - level 1 3.6 6 DAY T2N1M0
17.S.A - - - level 1-5  - - - - level 4 2.3 9 DAY T3N0M0
18.T.D level 1-5 level 2 and 5 1 and 1  level 1-5  level 3 and 4 1 and 1  level  2   3.6 level  2, 3, 3.6, 8.1 15 DAY T4N2bM0 
       and 5 and 1.1 and 4 and 1.4 
19.Ü.K level 1-4 - - level 2-5 - - - - - - 12 DAY T2N0M0
20.H.Ü level 1-5 - - level 1-5  - - level 1 and 2  4and 2.7 level 2 3.2 5 DAY T3N1M0
21.S.K level 1-5 - - level 2-4 - - - - - - 9 DAY T3N0M0
22.E.D level 1-5 level 2 1  level 1-3 - - level 2 2.7 - - 6 DAY T2N0M0
23.N.G level 1-2 - - level 1-3 - - - - - - 13 DAY T2N0M0
MLN: metastatic lymph node
SUV-max threshold value for metastasis was detected as 2.50 
with ROC curve according to histopathological examina-
tion and PET-CT data. The reliability of this threshold value 
was calculated as (AUC)=0.819 (Figure 1). Of 28 metastatic 
lymph nodes histopathologically detected with PET-CT in 
the patients with oral cavity cancer according to this threshold 
value, 25 of them were detected true positive and 3 of them 
were detected false negative results. Eleven of the 15 metas-
tasis levels with PET-CT were detected true positive and 4 
of them were detected false negative (Figure 2). False positive 
results in totally 16 levels and 16 lymph nodes were detected 
(Table 3). According to these data, when SUV-max threshold 
value is taken as 2.50, sensitivity, specifity, positive predictive 
value (PPV), negative predictive value (NPV), and accuracy 
were detected as 73%, 87%, 40.7%, 96.6% and 86% respectively 
for the region in determining cervical lymph node metastasis 
of PET-CT. When it was considered with respect to lymph 
node metastasis, , sensitivity, specifity, positive predictive val-
ue (PPV), negative predictive value (NPV), and accuracy were 
detected as 89%, 98%, 60.9%, 99.7% and 98.5% respectively 
(Table 4)
With regard to metastatic lymph node, histopathological exam-
ination and PET-CT concordance were determined as 0.416 
with Kappa concordance analysis.
Discussion
In oral cavity cancers, neck metastasis possibility is high due to 
rich lymphatic drainage. The rate of occult metastasis is fairly 
high in oral cavity cancers. Various rates changing between 34% 
and 42% have been reported in the literature. Due to these oc-
cult metastasis rates elective neck dissection indication to the 
patients arises. In the literature, there are also some defending 
the “wait and see” approach for clinical N0 necks (7). We apply 
the primary treatment approach to the neck in our clinic as ap-
plied to the patients having N0 neck. If our primary treatment 
approach is radiotherapy we also apply radiotherapy to the neck, 
if our approach is surgical then we conduct elective neck dissec-
tion and in the presence of suspicious involvement we add neck 
dissection to the location involved.
Early phase oral cavity SCC can be brought under control lo-
cally by surgery and/or radiotherapy successfully. However aside 
from primary tumor, doing the treatment planning of the neck 
regardfully is very important in the course of the disease (8, 9). 
The most important prognostic factor in head and neck cancers 
is the involvement of cervical lymph nodes. This is also valid for 
oral cavity cancers (10.11). The presence of metastasis in only 
one lymph node lowers the survival rate of the patient at a rate 
of almost 50% (10). Therefore, correct treatment of the cervical 
lymph nodes has critical importance for the patient.
Imaging methods are required in determining nodal metas-
tasis. PET-CT has taken its place after MRI and CT. PET is 
a nuclear medicine imaging technique effectiveness of which 
has been proved, showing the changes in function and me-
tabolism of organ and tissues with anatomical details. It is the 
most advanced medical imaging method used in detection 
of tumor especially in oncology, conducting staging, evalu-
ation of the response to the treatment, restaging in case of 
relapse/metastasis suspicion and rising of the tumor markers, 
radiotherapy planning and in detecting whether the tumor 
is benign or malignant (13). Since PET studies indicate the 
metabolic changes, it provides information about the lesion 
earlier than the other imaging methods and PET-CT stud-
ies contribute to the early diagnosis and correct staging of 
the disease due to the fact that anatomical localization and 
details are indicated with CT (14). In many studies conduct-
ed to determine lymph node metastasis, PET-CT has been 
found to have higher sensitivity (64%-100%) and specifity 
(67%- 100%) and a more frequently preferred method when 
compared to MRI and CT (15, 16).
In Piao et al.’s study (17) sensitivity, specifity, PPD and NPD 
and accuracy in detection of metastasis region in the neck were 
found as 84%, 87%, 75% and 94% respectively. The threshold 
value was determined as SUV-max>2.5. In the study of Mo-
chuziki et al. when threshold value is taken as 2.5 for SUV-max 
sensitivity, specifity, PPD and NPD and accuracy were found 
75%, 63.8%, 19.1%, 95.7% and 65% respectively. In Chun Ta 
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Table 3. Comparison of PET-CT and histopathological examination with 
regard to determination of the level and lymph node metastasis in the neck
                                            HISTOPATHOLOGICAL EXAMINATION
PET-CT Positive Negative
Level  
 Positive 11 (TP) 16 (FP)
 Negative 4 ( FN) 114 (TN)
Lymph Node  
 Positive 25 (TP) 16 (FP)
 Negative 3 ( FN) 1253 (TN)
 TP: true positive; FP: false positive; TN: true negative; FN: false negative  
Table 4. Sensitivity, specifity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of cervical lymph node metastasis 
and its region detected by PET-CT
 Sensitivity Specifity PPV  NPV Accuracy
Region 11/15 (73%) 114/130 (87%) 40.7% 96.6% 125/145(86%)
Lymph node 25/28 (89%) 1253/ 1269 (98%) 60.9% 99.7% 1278/1297(98.5%)
Liao et al.’s (19) study including 473 patients, when SUV-max 
threshold value is taken as 3.1, sensitivity and specifity were 
found 79.9% and 59.4% respectively. In our study when the 
threshold value is taken as 2.5 in detection of the metastatic 
region in the neck, sensitivity, specifity, PPD and NPD and 
accuracy were found 73%, 91%, 40.7%, 96.6% and 86% respec-
tively. These data obtained in our study were in line with the 
other studies. These results indicate that PET-CT nowadays 
has an important place to evaluate cervical lymph node metas-
tasis in oral cavity cancers.
In our study it was observed that there was FDG involvement 
with PET-CT in all metastatic lymph nodes of the neck. How-
ever complex anatomy of head and neck and accumulation of 
nonspecific physiological FDG may decrease 18F-FDG PET- 
CT effectiveness in head and neck region (20). In order to de-
tect metastatic lymph node with PET-CT and distinguish it 
from the physiological involvement, it is necessary to determine 
a threshold value. In this study when threshold SUV-max value 
is taken as 2.50 in the patients with oral cavity having FDG in-
volvement the sensitivity, specifity and accuracy of PET-CT in 
determining lymph node metastasis were found 89%, 98% and 
98.5% respectively. Consequently, it was seen that PET-CT can 
be used as a reliable method in determining metastatic lymph 
node of the neck in the patients with oral cavity SCC and treat-
ment planning. 
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